These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 24177357

  • 1. Synthesis, biological evaluation and molecular modeling studies of some novel thiazolidinediones with triazole ring.
    Chinthala Y, Kumar Domatti A, Sarfaraz A, Singh SP, Kumar Arigari N, Gupta N, Satya SK, Kotesh Kumar J, Khan F, Tiwari AK, Paramjit G.
    Eur J Med Chem; 2013; 70():308-14. PubMed ID: 24177357
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, in vitro biological activities and in silico study of dihydropyrimidines derivatives.
    Barakat A, Islam MS, Al-Majid AM, Ghabbour HA, Fun HK, Javed K, Imad R, Yousuf S, Choudhary MI, Wadood A.
    Bioorg Med Chem; 2015 Oct 15; 23(20):6740-8. PubMed ID: 26381063
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
    Zhang YB, Wang XL, Liu W, Yang YS, Tang JF, Zhu HL.
    Bioorg Med Chem; 2012 Nov 01; 20(21):6356-65. PubMed ID: 23018096
    [Abstract] [Full Text] [Related]

  • 4. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M, Mohammadi-Khanaposhtani M, Pourrabia P, Razzaghi N, Ghadimi R, Imanparast S, Faramarzi MA, Bandarian F, Esfahani EN, Safavi M, Rastegar H, Larijani B, Mahdavi M, Akbarzadeh T.
    Bioorg Chem; 2019 Mar 01; 83():161-169. PubMed ID: 30366316
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
    Duan YC, Ma YC, Zhang E, Shi XJ, Wang MM, Ye XW, Liu HM.
    Eur J Med Chem; 2013 Apr 01; 62():11-9. PubMed ID: 23353743
    [Abstract] [Full Text] [Related]

  • 6. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
    Ma LY, Pang LP, Wang B, Zhang M, Hu B, Xue DQ, Shao KP, Zhang BL, Liu Y, Zhang E, Liu HM.
    Eur J Med Chem; 2014 Oct 30; 86():368-80. PubMed ID: 25180925
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
    Sun J, Zhu H, Yang ZM, Zhu HL.
    Eur J Med Chem; 2013 Feb 30; 60():23-8. PubMed ID: 23279864
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and antiproliferative activity of 8-hydroxyquinoline derivatives containing a 1,2,3-triazole moiety.
    Freitas LB, Borgati TF, de Freitas RP, Ruiz AL, Marchetti GM, de Carvalho JE, da Cunha EF, Ramalho TC, Alves RB.
    Eur J Med Chem; 2014 Sep 12; 84():595-604. PubMed ID: 25062010
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
    Huang XF, Lu X, Zhang Y, Song GQ, He QL, Li QS, Yang XH, Wei Y, Zhu HL.
    Bioorg Med Chem; 2012 Aug 15; 20(16):4895-900. PubMed ID: 22819191
    [Abstract] [Full Text] [Related]

  • 10. Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies.
    Rostom SAF, Badr MH, Abd El Razik HA, Ashour HMA.
    Eur J Med Chem; 2017 Oct 20; 139():263-279. PubMed ID: 28803043
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
    Pingaew R, Mandi P, Nantasenamat C, Prachayasittikul S, Ruchirawat S, Prachayasittikul V.
    Eur J Med Chem; 2014 Jun 23; 81():192-203. PubMed ID: 24836071
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, docking and ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity.
    Chinthala Y, Thakur S, Tirunagari S, Chinde S, Domatti AK, Arigari NK, K V N S S, Alam S, Jonnala KK, Khan F, Tiwari A, Grover P.
    Eur J Med Chem; 2015 Mar 26; 93():564-73. PubMed ID: 25743216
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and evaluation of anticancer and antiobesity activity of 1-ethoxy carbonyl-3,5-bis (3'-indolyl methylene)-4-pyperidone analogs.
    Buduma K, Chinde S, Dommati AK, Sharma P, Shukla A, Srinivas KVNS, Arigari NK, Khan F, Tiwari AK, Grover P, Jonnala KK.
    Bioorg Med Chem Lett; 2016 Mar 15; 26(6):1633-1638. PubMed ID: 26873414
    [Abstract] [Full Text] [Related]

  • 14. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation.
    Kumar K, Sagar S, Esau L, Kaur M, Kumar V.
    Eur J Med Chem; 2012 Dec 15; 58():153-9. PubMed ID: 23124212
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, biological activity, and molecular modeling studies of 1H-1,2,3-triazole derivatives of carbohydrates as alpha-glucosidases inhibitors.
    Ferreira SB, Sodero AC, Cardoso MF, Lima ES, Kaiser CR, Silva FP, Ferreira VF.
    J Med Chem; 2010 Mar 25; 53(6):2364-75. PubMed ID: 20170190
    [Abstract] [Full Text] [Related]

  • 16. From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.
    Buscató E, Büttner D, Brüggerhoff A, Klingler FM, Weber J, Scholz B, Zivković A, Marschalek R, Stark H, Steinhilber D, Bode HB, Proschak E.
    ChemMedChem; 2013 Jun 25; 8(6):919-23. PubMed ID: 23596124
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and anticancer activity evaluation of a series of [1,2,4]triazolo[1,5-a]pyridinylpyridines in vitro and in vivo.
    Wang XM, Xu J, Li YP, Li H, Jiang CS, Yang GD, Lu SM, Zhang SQ.
    Eur J Med Chem; 2013 Sep 25; 67():243-51. PubMed ID: 23871904
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group.
    Chen PC, Patil V, Guerrant W, Green P, Oyelere AK.
    Bioorg Med Chem; 2008 May 01; 16(9):4839-53. PubMed ID: 18397827
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.